TY  - JOUR
AU  - Yonesaka, Kimio
PY  - 2026
TI  - Trophoblast cell-surface antigen 2-targeted “sacituzumab tirumotecan”: a new approach for epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small cell lung cancer
JF  - Translational Lung Cancer Research; Vol 15, No 7 (July 31, 2026): Translational Lung Cancer Research
Y2  - 2026
KW  - 
N2  - 
UR  - https://tlcr.amegroups.org/article/view/122239